AU2002322169B2 - Derivatives of morphine-like opioid compounds - Google Patents
Derivatives of morphine-like opioid compounds Download PDFInfo
- Publication number
- AU2002322169B2 AU2002322169B2 AU2002322169A AU2002322169A AU2002322169B2 AU 2002322169 B2 AU2002322169 B2 AU 2002322169B2 AU 2002322169 A AU2002322169 A AU 2002322169A AU 2002322169 A AU2002322169 A AU 2002322169A AU 2002322169 B2 AU2002322169 B2 AU 2002322169B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- radical
- reacting
- krs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002322169A AU2002322169B2 (en) | 2001-08-10 | 2002-08-09 | Derivatives of morphine-like opioid compounds |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6938 | 2001-08-10 | ||
| AUPR6938A AUPR693801A0 (en) | 2001-08-10 | 2001-08-10 | Therapeutic compounds |
| AUPR9640A AUPR964001A0 (en) | 2001-12-19 | 2001-12-19 | Therapeutic compounds |
| AUPR9640 | 2001-12-19 | ||
| PCT/AU2002/001088 WO2003014122A1 (en) | 2001-08-10 | 2002-08-09 | Derivatives of morphine-like opioid compounds |
| AU2002322169A AU2002322169B2 (en) | 2001-08-10 | 2002-08-09 | Derivatives of morphine-like opioid compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002322169A1 AU2002322169A1 (en) | 2003-06-19 |
| AU2002322169B2 true AU2002322169B2 (en) | 2008-10-30 |
Family
ID=25646773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002322169A Ceased AU2002322169B2 (en) | 2001-08-10 | 2002-08-09 | Derivatives of morphine-like opioid compounds |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7199129B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1423392B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005500373A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE341552T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002322169B2 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60215195T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003014122A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040204862A1 (en) * | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| US9351973B2 (en) | 2011-09-22 | 2016-05-31 | Merck Sharp & Dohme Corp. | Pyrazolopyridyl compounds as aldosterone synthase inhibitors |
| WO2013043518A1 (en) | 2011-09-22 | 2013-03-28 | Merck Sharp & Dohme Corp. | Imidazopyridyl compounds as aldosterone synthase inhibitors |
| EP2757883B1 (en) | 2011-09-22 | 2021-01-13 | Merck Sharp & Dohme Corp. | Triazolopyridyl compounds as aldosterone synthase inhibitors |
| WO2014015157A2 (en) | 2012-07-19 | 2014-01-23 | Philadelphia Health & Education Corporation | Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
| US9920836B2 (en) * | 2013-10-18 | 2018-03-20 | Kabushiki Kaisha Riken | Piston ring for internal combustion engine |
| US11117870B2 (en) | 2017-11-01 | 2021-09-14 | Drexel University | Compounds, compositions, and methods for treating diseases |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3341538A (en) * | 1965-06-18 | 1967-09-12 | Geigy Chem Corp | Certain 2, 6-methano-3-benzazocines |
| WO1999038869A1 (en) * | 1998-01-29 | 1999-08-05 | Monash University | Therapeutic compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100602929B1 (ko) * | 2000-08-31 | 2006-07-20 | 에프. 호프만-라 로슈 아게 | 알파-1 아드레날린성 길항제로서 퀴나졸린 유도체 |
-
2002
- 2002-08-09 AU AU2002322169A patent/AU2002322169B2/en not_active Ceased
- 2002-08-09 JP JP2003519071A patent/JP2005500373A/ja not_active Abandoned
- 2002-08-09 DE DE60215195T patent/DE60215195T2/de not_active Expired - Fee Related
- 2002-08-09 EP EP02753923A patent/EP1423392B1/en not_active Expired - Lifetime
- 2002-08-09 US US10/486,536 patent/US7199129B2/en not_active Expired - Fee Related
- 2002-08-09 AT AT02753923T patent/ATE341552T1/de not_active IP Right Cessation
- 2002-08-09 WO PCT/AU2002/001088 patent/WO2003014122A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3341538A (en) * | 1965-06-18 | 1967-09-12 | Geigy Chem Corp | Certain 2, 6-methano-3-benzazocines |
| WO1999038869A1 (en) * | 1998-01-29 | 1999-08-05 | Monash University | Therapeutic compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003014122A1 (en) | 2003-02-20 |
| EP1423392A4 (en) | 2004-11-17 |
| ATE341552T1 (de) | 2006-10-15 |
| US20040242616A1 (en) | 2004-12-02 |
| DE60215195D1 (de) | 2006-11-16 |
| JP2005500373A (ja) | 2005-01-06 |
| US7199129B2 (en) | 2007-04-03 |
| DE60215195T2 (de) | 2007-08-23 |
| EP1423392A1 (en) | 2004-06-02 |
| EP1423392B1 (en) | 2006-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6784186B1 (en) | Therapeutic compounds | |
| US6534514B1 (en) | Kappa opioid receptor antagonists | |
| KR102038260B1 (ko) | 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 | |
| JP6794602B2 (ja) | ポリアミド化合物及びその使用 | |
| EP2046800B1 (en) | 6-carboxy-normorphinan derivatives, synthesis and uses thereof | |
| US5739145A (en) | Antitussive agents | |
| AU4300799A (en) | Imidazo pyridine derivatives which inhibit gastric acid secretion | |
| AU2003290630A1 (en) | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts | |
| JPWO1993015081A1 (ja) | モルヒナン誘導体および医薬用途 | |
| KR20090086627A (ko) | 프로드러그 및 그것의 제조 및 사용 방법 | |
| US20120149900A1 (en) | Fluorine containing compounds and methods of use thereof | |
| EP1423392B1 (en) | Derivatives of morphine-like opioid compounds | |
| US20090156630A1 (en) | Anti-tumour polycyclic carboxamides | |
| EP2398807A1 (en) | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives | |
| HUP0500024A2 (hu) | 6-Aminomorfinán-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
| AU2002322169A1 (en) | Derivatives of morphine-like opioid compounds | |
| JP2014073964A (ja) | モルヒナン誘導体 | |
| EP0770081B1 (en) | Heterocycle-condensed morphinoid derivatives | |
| US5834478A (en) | Morphinan hydroxamic acid compounds | |
| US20060111381A1 (en) | Amidine compounds | |
| US6271239B1 (en) | Delta opioid receptor-selective benzylidene-substituted morphinans | |
| AU2003266841A1 (en) | Amidine compounds | |
| JP2005500373A5 (cg-RX-API-DMAC7.html) | ||
| AU757975C (en) | Therapeutic compounds | |
| WO2000008027A1 (en) | Kappa (op2) opioid receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |